Update: Corrected to accurately reflect the company admitted to no wrongdoing in its Dept. of Justice case. EndoGastric Solutions said today it raised $50 million in a new round of financing for its EsophyX acid reflux treatment device. The company makes endoscopic surgical equipment for transoral incisionless fundoplication, tissue-stapling in the stomach and esophagus, designed […]
endogastricsolutions
Fujifilm Medical Systems names new COO, CMO | Personnel Moves
Fujifilm Holdings (TSE:4901) said its Fujifilm Medical Systems U.S.A. subsidiary lured an Accuray (NSDQ:ARAY) executive and a physician from the University of Southern California to its executive roster effective Sept. 28. The Stamford, Conn.-based company said Johann Fernando, formerly Accuray’s vice president & general manager, was named to be its operations chief. Dr. Diku Mandavia, who has […]
GI Dynamics axes medical chief Maggs | Personnel Moves
GI Dynamics (ASX:GID) said last week in a regulatory filing that it fired chief medical officer Dr. David Maggs “for cause.” The Lexington, Mass.-based medical device company did not otherwise elaborate on the reason for Maggs’s departure, which was effective June 18, according to the filing. Maggs joined GI Dynamics in April 2013 to oversee the clinical […]
GI Dynamics raises $32M in private placement with group overseas | Medtech funding stories for the week of May 5, 2014
EndoGastric Solutions raises $30M in support of acid reflux device
California-based EndoGastric Solutions touted $30 million raised in a Series G fundraising round in support of its acid reflux treatment device.
Apple hints at medical device app as they hire more medical sensor experts | Medtech personnel moves for the week of May 5, 2014
Orthofix taps ex-AMS finance chief Heggestad to be new CFO
EndoGastric Solutions pays $5.3M to settle Justice Dept. probe
California medical device maker EndoGastric Solutions agreed this month to pay $5.3 million plus interest to settle Justice Dept. allegations that the company engaged in Medicare fraud and illegal kickbacks to promote its EsophyX acid reflux disease treatment device.
Medtronic’s Irish profits rise 119% | Wall Street Beat
Docs resist prostate test recommendation | MassDevice.com On Call
MASSDEVICE ON CALL — Primary care docs surveyed by Johns Hopkins University researchers say they’re unlikely to curtail their use of a test to detect prostate cancer, despite recommendations from the U.S. Preventive Services Task Force.
The USPSTF stirred up a controversy last year when it suggested that routine prostate-specific antigen tests for healthy men might do more harm than good.
California endovascular firms drum up $45 million
California-based EndoGastric Solutions Inc. and Aptus EndoSystems Inc. brought in $30 million and $15 million, respectively, in separate funding rounds.
Menlo Park, Calif.-based Canaan Partners and New York-based Radius Ventures led EndoGastric’s $30 million Series F round, which was designed to support the company through profitability, according to a press release.